China’s Hansoh Pharma re-files for Hong Kong IPO

Hansoh Pharmaceutical Group Co Ltd has re-filed its application to conduct an initial public offering (IPO) in Hong Kong that could fetch the Chinese drug-maker at least $500 million, people with direct knowledge of the matter said on Friday.

Continue reading this story with a subscription to DealStreetAsia.


Contact us for corporate subscriptions at